These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8057449)

  • 61. Full length antigen priming enhances the CTL epitope-based DNA vaccine efficacy.
    Pouriayevali MH; Bamdad T; Parsania M; Sari RD
    Cell Immunol; 2011; 268(1):4-8. PubMed ID: 21324438
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.
    De Bruijn ML; Nieland JD; Schumacher TN; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1992 Nov; 22(11):3013-20. PubMed ID: 1425925
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice.
    Willis RA; Bowers WJ; Turner MJ; Fisher TL; Abdul-Alim CS; Howard DF; Federoff HJ; Lord EM; Frelinger JG
    Hum Gene Ther; 2001 Oct; 12(15):1867-79. PubMed ID: 11589829
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.
    Actor JK; Shirai M; Kullberg MC; Buller RM; Sher A; Berzofsky JA
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):948-52. PubMed ID: 8094248
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.
    Brehm MA; Bonneau RH; Knipe DM; Tevethia SS
    J Virol; 1997 May; 71(5):3534-44. PubMed ID: 9094625
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes.
    Fujimoto C; Nakagawa Y; Ohara K; Takahashi H
    Int Immunol; 2004 Jan; 16(1):55-63. PubMed ID: 14688061
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes.
    Zuckermann FA; Zsak L; Mettenleiter TC; Ben-Porat T
    J Virol; 1990 Feb; 64(2):802-12. PubMed ID: 2153244
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Selective induction of high avidity CTL by altering the balance of signals from APC.
    Oh S; Hodge JW; Ahlers JD; Burke DS; Schlom J; Berzofsky JA
    J Immunol; 2003 Mar; 170(5):2523-30. PubMed ID: 12594278
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Generation of antigen-specific CD8+ CTLs from naive precursors.
    Mehta-Damani A; Markowicz S; Engleman EG
    J Immunol; 1994 Aug; 153(3):996-1003. PubMed ID: 8027569
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
    Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
    J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeted delivery of DNA encoding herpes simplex virus type-1 glycoprotein D enhances the cellular response to primary viral challenge.
    Rogers JV; Bigley NJ; Chiou HC; Hull BE
    Arch Dermatol Res; 2000 Nov; 292(11):542-9. PubMed ID: 11194892
    [TBL] [Abstract][Full Text] [Related]  

  • 75. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
    Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
    Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
    J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
    Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
    Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes.
    Torpey DJ; Lindsley MD; Rinaldo CR
    J Immunol; 1989 Feb; 142(4):1325-32. PubMed ID: 2464644
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells.
    Yasukawa M; Inatsuki A; Kobayashi Y
    J Immunol; 1989 Sep; 143(6):2051-7. PubMed ID: 2476493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.